Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
|ClinicalTrials.gov Identifier: NCT00001912|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : July 2, 2017
This study will examine what causes seizures in patients with cysticercosis (pork tapeworm infection). A better understanding of this could lead to improved methods of controlling or preventing seizures.
In humans, the pork tapeworm (Taenia solium) lives in the small intestine. The parasite's microscopic eggs travel around the body-including to the brain-where they develop into cysts. Usually, the cysts don't cause symptoms until they die. Then, they provoke an inflammatory reaction that irritates the brain, causing seizures and other symptoms. The inflammation eventually goes away, but the dead cysts remain. Calcium deposits often form where the cysts are. Some of the calcified cysts develop swelling around them that seem to be associated with the development of seizures.
This study will explore how and why these dead, calcified cysts continue to cause seizures. In so doing, it will try to determine: 1) the best diagnostic imaging method for detecting swelling around the cysts; 2) how often swelling occurs; and 3) what makes some cysts prone to swelling and related seizure activity, while others are not.
Patients with cysticercosis who have had seizures or who have known or possible swelling around calcified cysts will be studied with various tests, including magnetic resonance imaging (MRI), computed tomography (CT) scans, electroencephalography (EEG), blood tests, and possibly lumbar puncture. Patients will be studied for two cycles of seizures (during active and quiet periods) or a maximum 4 years.
|Condition or disease|
|Cysticercosis Cysts Seizures|
|Study Type :||Observational|
|Actual Enrollment :||6 participants|
|Official Title:||Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis|
|Study Start Date :||August 10, 1999|
|Estimated Study Completion Date :||April 4, 2012|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001912
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Universidad Peruana Cayetano Heredia|
|Principal Investigator:||Henry Masur, M.D.||National Institutes of Health Clinical Center (CC)|